Semler Scientific, INC Form 4 insider transactions
Director Daniel S. Messina acquired stock options in Semler Scientific, Inc. on May 2, 2025.
Director William H. Chang acquired stock options in Semler Scientific, Inc. on May 2, 2025, according to a Form 4 filing.
Semler Scientific's CEO, Douglas Murphy-Chutorian, was granted 50,000 stock options on January 6, 2025, which vest over four years.
Director William H. Chang of Semler Scientific, Inc. acquired stock options for 8,125 shares on January 6, 2025.
William H. Chang, a director at Semler Scientific, transferred 2,182 shares of common stock to his family trust as part of a director compensation award.
A Semler Scientific director amended a previous filing to reflect the transfer of shares received as director compensation to a family trust, resulting in no direct ownership of shares by the director.
Semler Scientific's Chief Financial Officer, Renae Cormier, has acquired 40,000 stock options, exercisable over a four-year vesting period.
Director Daniel Messina acquired stock options in Semler Scientific, Inc. on January 6, 2025.
Director Eric Semler acquired stock options for Semler Scientific, Inc. on January 6, 2025.
Director William H. Chang of Semler Scientific, Inc. gifted 2,735 shares of common stock to family members on December 16, 2024.
Director Eric Semler exercised stock options to acquire 7,875 shares of Semler Scientific, Inc. common stock at a price of $23.32 per share.
Semler Scientific's CEO, Douglas Murphy-Chutorian, exercised stock options and sold a significant number of shares over a three-day period.
Form 4: Semler Scientific CEO Douglas Murphy-Chutorian Executes Stock Options and Disposes of Shares
Douglas Murphy-Chutorian, CEO of Semler Scientific, exercised stock options and disposed of shares, according to a recent SEC Form 4 filing.
Director Eric Semler reports acquisition of 50,000 shares and disposition of 1,318 shares of Semler Scientific stock.
Director William H. Chang reports acquiring 1,318 shares of Semler Scientific, Inc. common stock on November 7, 2024.
Director Daniel Messina reported acquiring 1,318 shares of Semler Scientific common stock and disposing of 11,910 shares on November 7, 2024.
Douglas Murphy-Chutorian, CEO of Semler Scientific, Inc., gifted shares of common stock to a family trust.
Douglas Murphy-Chutorian, CEO of Semler Scientific, sold a portion of his holdings in the company's common stock on August 28th and 29th, 2024.
Douglas Murphy-Chutorian, CEO of Semler Scientific, exercised a stock option for 71,000 shares and disposed of shares to cover the exercise price and tax withholding.
Semler Scientific's CEO, Douglas Murphy-Chutorian, recently sold shares of the company's common stock in multiple transactions.
Douglas Murphy-Chutorian, CEO of Semler Scientific, exercised stock options and sold 71,000 shares of common stock on August 26, 2024.
Director William H. Chang acquired 27,000 stock options in Semler Scientific, Inc. as part of non-employee director compensation.
Director Eric Semler acquired 27,000 stock options in Semler Scientific, Inc. as part of non-employee director compensation.
Director Eric Semler reports acquiring shares of Semler Scientific and disclaims beneficial ownership of shares held by TCS Capital Advisors, LLC.
William Chang, a director and 10% owner of Semler Scientific, reported the acquisition of 2,182 shares of common stock and provided an update on their beneficial ownership.
Semler Scientific's CEO, Douglas Murphy-Chutorian, was granted stock options for 15,000 shares on May 10, 2024, according to a Form 4 filing.
Director Daniel Messina acquired 2,182 shares of Semler Scientific, Inc. common stock on May 10, 2024, as part of the company's non-employee director compensation policy.
Renae Cormier, CFO of Semler Scientific, Inc., reported the acquisition of stock options on May 10, 2024.